Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

soho flordis uk ltd. - panax ginseng, root, powder 100 mg - capsule, soft - 100 mg - panax ginseng, root, powder 100 mg - tonics

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

soho flordis uk ltd. - prunus africana, extract 25 mg; urticae dioicae, root, dry extract 300 mg - capsule, soft - 25 mg - 300 mg - prunus africana, extract 25 mg; urticae dioicae, root, dry extract 300 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soho flordis uk ltd - oral capsule

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soho flordis uk ltd - chewable capsule

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soho flordis uk ltd - oral liquid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soho flordis uk ltd - oral capsule

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soho flordis uk ltd - oral liquid

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

delfi marketing sdn.bhd. - alpha-cyclodextrin* -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - cape aloes; cascara; taraxacum; fennel; senna leaf powdered - oral tablet - 45mg ; 30mg ; 30mg ; 15mg ; 100mg

United States - English - NLM (National Library of Medicine)

ipsen biopharmaceuticals, inc. - palovarotene (unii: 28k6i5m16g) (palovarotene - unii:28k6i5m16g) - sohonos is indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (fop). sohonos is contraindicated in the following patients: - during pregnancy [see warnings and precautions (5.1) and use in specific populations (8.1)] . - a history of allergy or hypersensitivity to retinoids, or to any component of sohonos. anaphylaxis and other allergic reactions have occurred with other retinoids. [see description (11)]. risk summary sohonos is contraindicated during pregnancy. based on the findings in animal studies and class effects of retinoids, sohonos can cause fetal harm when administered during pregnancy [see warnings and precautions (5.1) and use in specific populations (8.3)] . in animal reproduction studies, oral administration of palovarotene to pregnant rats during the period of organogenesis resulted in multiple fetal malformations typical of retinoids